Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Journal of Imaging Informatics in Medicine|December 11, 2025
Block Matching Based Speckle Tracking Echocardiography: Clinical Applications and Research Outlook in a Deep Learning ContextYufan Zhao, Guolong Pang, Zhengxiang Sun, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 7, 2025
Enterolactone combined with m6A Reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancerMengzhi Xu, Yi Guo, Fengge Wang, et al.Journal of Cancer|August 14, 2023
Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against CancerLingJie Luo, Caiji Lin, Pengfei Wang, et al.Current Pharmaceutical Design|May 27, 2022
Trabectedin in Cancers: Mechanisms and Clinical ApplicationsJiali Wang, Pengfei Wang, Zheng Zeng, et al.Journal for Immunotherapy of Cancer|March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanomaGeoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.Gynecologic Oncology|July 13, 2017
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancerRebecca Kristeleit, Irina Davidenko, Vadim Shirinkin, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 27, 2022
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiotaCaiji Lin, Zheng Zeng, Yiru Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C Mitchell, Omid Hamid, David C Smith, et al.British Journal of Pharmacology|November 13, 2025
Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosisDanli Cao, Caiji Lin, Jiaxing Wang, et al.Journal of Natural Products|April 11, 2024
Cannabidiol Inhibits Epithelial Ovarian Cancer: Role of Gut MicrobiomeDanli Cao, Yiru Lin, Caiji Lin, et al.Pageof 5